David Nierengarten: Stocks like Y-mAbs Therapeutics Which Have Advanced Assets as Well as Upside Potential 09.04.2019 For more on David Nierengarten’s: Wedbush: Y-mAbs Could Attract Investor Attention As Market Volatility Grows